Jeff Macdonald | IR |
Mark Velleca | CEO |
Buck Phillips | CFO and SVP, Corporate Development |
Raj Malik | Chief Medical Officer, SVP, R&D |
Chris Shibutani | Cowen & Co. |
Chad Messer | Needham and Company |
Good afternoon. My name is Jesse and I'll be your conference operator today. At this time, I would like to welcome everyone to the G1 Therapeutics Second Quarter 2018 Corporate Update. [Operator Instructions] Thank you. Jeff Macdonald, Head of Investor Relations, you may begin your conference.